Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

London Vet Show 2025: join our talks

Key Takeaway: The London Vet Show 2025 will feature two sessions led by Dr. Tom Butera, CEO of Volition Veterinary, focusing on early cancer detection in dogs. The talks will cover the practical applications of the Nu.Q® Vet Cancer Test in clinical settings, emphasizing its role in routine screening and preventive care. Attendees will gain insights on integrating this innovative tool into their practices.
Price reaction · baseline $6.318 (2025-11-17 close) · hit pre-market · clean, no other VNRX news in the window
day 0 close · peak
+10.8%
day 1
+3.7%
day 3
+1.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Dr. Tom Butera will share valuable insights on early cancer detection.
  • The Nu.Q® Vet Cancer Test is positioned to revolutionize wellness care for dogs.
  • Sessions provide practical applications that can improve patient outcomes.

Full Press Release Details

We’re excited to invite you to two exclusive sessions at the London Vet Show 2025 , where Dr. Tom Butera, Volition Veterinary CEO with years of experience in veterinary oncology will share his insights on early cancer detection and practical applications of the Nu.Q ® Vet Cancer Test in clinical settings.
📅 November 20th, 9:00 AM – 9:50 AM 📍 Exhibitor Showcase Theatre 2 💡 Talk: Early Detection with Canine Cancer Screening
Cancer is one of the leading causes of death in dogs, but early detection can dramatically improve outcomes. In this session, Dr. Butera will explore the role of routine screening in identifying cancer in asymptomatic dogs and how tools like the Nu.Q ® Vet Cancer Test are revolutionizing wellness care. Learn how to bring early detection into everyday practice, and how it could save more dogs’ lives.
📅 November 21st, 10:05 AM – 10:55 AM 📍 Gallery Suite 22 💡 Talk: Utilising the Nu.Q ® Vet Cancer Test in Practice
Ready to apply the science? This practical session offers guidance for integrating the Nu.Q ® Vet Cancer Test into your clinic’s workflow. Dr Butera will share clinical tips, real-world case examples, and strategies for effective client communication, helping you confidently integrate this innovative screening tool into your preventive care programs.
Whether you’re a veterinarian, technician, or practice manager, these sessions offer valuable tools to improve patient outcomes and enhance your practice with cutting-edge diagnostics.
Don’t miss out: mark your schedules and join us for both sessions!

Related Articles

• Webinars Utilizing the Nu.Q® Vet Cancer Test in Your Practice Webinar
• Press Releases Volition to Host Virtual Investor Event on Nu.Q® Cancer, “A Look to the Future of Cancer Diagnostics”, on April 9, 2025

Utilizing the Nu.Q® Vet Cancer Test in Your Practice Webinar

Volition to Host Virtual Investor Event on Nu.Q® Cancer, “A Look to the Future of Cancer Diagnostics”, on April 9, 2025

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What is the focus of Dr. Butera's talks?

Dr. Butera's talks will focus on early cancer detection and the Nu.Q® Vet Cancer Test.

When are the sessions at the London Vet Show 2025?

The sessions are on November 20th and 21st, 2025.

Who should attend these sessions?

Veterinarians, technicians, and practice managers will benefit from these sessions.

What will attendees learn about the Nu.Q® Vet Cancer Test?

Attendees will learn how to integrate the Nu.Q® Vet Cancer Test into clinical practice.

Last updated: Nov 18, 2025